Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 3.6B | 3.3B | 3.5B | 3.8B |
Cost of revenue | 2.2B | 2.1B | 2.3B | 2.3B |
Gross profit | 1.3B | 1.2B | 1.2B | 1.5B |
Operating expense | ||||
Research & development | 218.8M | 222M | 206.5M | 198.4M |
Selling general and admin | 928.7M | 948.1M | 1.0B | 1.0B |
Other operating expenses | — | — | — | — |
Operating income | 185.4M | -8.9M | -38.2M | 257.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 116.6M | 115.5M | 120.2M | 145.6M |
Other income expense | -285.9M | -3.0B | -368.1M | -21.3M |
Pretax income | -217.1M | -3.1B | -526.5M | 90.5M |
Tax provision | -212.5M | -55M | -10M | -4.3M |
Net income | -4.6M | -3.0B | -516.5M | 94.8M |
Basic EPS | 0 | -2.6 | -0.4 | 0.1 |
Diluted EPS | 0 | -2.6 | -0.4 | 0.1 |
Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
EBITDA | 530.2M | 556.5M | 481.5M | 937.3M |
Net income from continuing op. | -4.6M | -3.0B | -516.5M | 94.8M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |